ARTHQ — Arch Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.36m
- $0.08m
Brief: Arch Therapeutics Raises Approximately $3.5 Million In Convertible Note Financing
Brief: Arch Raises About $1.1 Mln With Convertible Note Issuance
Brief: Arch Therapeutics Receives Marketing Clearance From The US FDA Related To The AC5 Topical Gel Supply Chain
Brief: Arch Therapeutics Withdraws 510(K) With Plans To Resubmit After Further Discussions With FDA
Brief: Arch Therapeutics says AC5 topical hemostatic device stopped bleeding in patients in clinical study